Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | BB-1701 |
Trade Name | |
Synonyms | BB 1701|BB1701 |
Drug Descriptions |
BB-1701 is an antibody-drug conjugate (ADC) comprising an antibody targeting ERBB2 (HER2) conjugated to eribulin, which potentially induces cytotoxicity against tumor cells expressing ERBB2 (HER2) and leads to inhibition of tumor growth (Cancer Res (2023) 83 (7_Supplement): 1887). |
DrugClasses | HER2 (ERBB2) Antibody 76 HER2 (ERBB2) Antibody-Drug Conjugate 31 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
BB-1701 | BB-1701 | 0 | 2 |